Raj, Nitya MD*; Valentino, Emily BA*; Capanu, Marinela PhD†; Tang, Laura H. MD, PhD‡; Basturk, Olca MD‡; Untch, Brian R. MD§; Allen, Peter J. MD§; Klimstra, David S. MD‡; Reidy-Lagunes, Diane MD, MS*
From the Departments of *Medicine, †Biostatistics, ‡Pathology, and §Surgery, Memorial Sloan Kettering Cancer Center, New York, NY.
Received for publication May 19, 2016; accepted September 2, 2016.
Address correspondence to: Nitya Raj, MD, Division of Solid Tumor Oncology, Gastrointestinal Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, 300 East 66th Street, 1007, New York, NY 10065 (e-mail: [email protected]).
Conflicts of Interest and Source of Funding: Dr. Diane Reidy-Lagunes has received honoraria and research funding from Novartis. In addition, Dr. Reidy-Lagunes does consulting/advising for Novartis, Ipsen, and Pfizer. Dr. Peter Allen does consulting/advising for Sanofi. In addition, Dr. Allen has received research funding from Novartis. For the remaining authors none were declared. This work had no specific funding.
